$44.62
3M Ago | 1M Ago | Current | |
Buy | 11 | 11 | 11 |
Outperform | 8 | 8 | 8 |
Hold | 12 | 13 | 13 |
Underperform | 0 | 0 | 0 |
Sell | 3 | 3 | 3 |
The latest share price target for Crispr Therapeutics Ag (CRSP) is $81.21, offered by 35 analysts offering 12-month price forecasts.
Crispr Therapeutics Ag (CRSP) has a maximum of 0.82 upside potential, based on 35 analysts offering 12-month price forecasts.
Based on 35 analysts tracking and researching Crispr Therapeutics Ag (CRSP), 37.14% have a hold recommendation. Remaining 62.86% have either buy or sell recommendations.
The latest share price of Crispr Therapeutics Ag (CRSP) is $44.62 as of 07/09/2024.
13 of total 35 analysts offering stock ratings for Crispr Therapeutics Ag CRSP have recommended hold rating.